Med. praxi. 2018;15(4):189-193 | DOI: 10.36290/med.2018.036

Pharmacotherapy of back and joint pain in general practitioner’s office

MUDr. Libuše Ircingová
Centrum léčby bolesti KARIM, FN Plzeň

General physicians as well as many specialists in both ambulatory and hospital care need to deal with joint – and back – painon daily basis. The aim of this paper is to summarize the possibilities of pain pharmacotherapy, distinguising between the acuteand the chronic pain, the nociceptive and neuropathic chracter of the pain, and also to reflect on specifics of treating pain in theelderly. It also includes a stratégy for the rational opioid treatment in patients with chronic noncancerous pain.

Keywords: back pain, pain in old age, opioid treatment

Published: September 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ircingová L. Pharmacotherapy of back and joint pain in general practitioner’s office. Med. praxi. 2018;15(4):189-193. doi: 10.36290/med.2018.036.
Download citation

References

  1. Fricová J, Hakl M. Metodické pokyny pro farmakoterapii bolesti. Bolest. 2017; 20(1): 3-4.
  2. Kozák J, Lejčko J, Vrba I. Opioidy. Praha: Mladá fronta 2018.
  3. Hart R, et al. Degenerativní onemocnění páteře, Praha: Galén 2014.
  4. Hodis J. Nová fakta o paracetamolu, rizika předávkování, intoxikace a jejich zvládání. Praktické lékárenství. 2015; 11(3): 90-92.
  5. Suchý D, Hromádka M. Analýza rizik léčby bolesti nesteroidními antirevmatiky a paracetamolem. Bolest. 2015; 18(2): 81-87.
  6. Castellsague J, Riera-Guarda N, Calingaert B, et al. Individual NSAIDs and Upper Gastrointestinal Complications. Drug Saf. 2012; 35(12): 1127-1146. Go to original source...
  7. Varas-Lorenzo C, Riera-Guarda N, Calingaert B, et al. Myocardial infarction and individual NSAIDs meta-analysis of observational studies. Pharmacoepidemiology and drug safety. 2013; 22: 559-570. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.